ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.59
1.05%
US Tech 100
20,332.80
1.61%
S&P 500
5,954.50
1.59%
US Dollar vs CAD
1.44344
-0.05%
Bitcoin
93,004.48
-1.32%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Regeneron Pharmaceuticals Inc (0R2M) Share Price

Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc (0R2M)

LSE
296.60
0.00
(0.00%)
Closed March 02 10:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
296.60
Bid
0.00
Ask
0.00
Volume
266
0.00 Day's Range 0.00
296.60 52 Week Range 296.60
Market Cap
32.054B
Previous Close
296.60
Open
-
Last Trade
1
@
699.1111
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,261
Shares Outstanding
108,072,000
Dividend Yield
-
PE Ratio
17.11
Earnings Per Share (EPS)
40.83
Revenue
14.2B
Net Profit
4.41B

About Regeneron Pharmaceuticals Inc

Sector
Pharmaceutical Preparations
Industry
Health Care Diversified
Website
www.regeneron.com
Headquarters
New York, New York, USA
Founded
1988
Regeneron Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0R2M. The last closing price for Regeneron Pharmaceuticals was US$296.60. Over the last year, Regeneron Pharmaceuticals shares have traded in a share price range of US$ 296.60 to US$ 296.60.

Regeneron Pharmaceuticals currently has 108,072,000 shares outstanding. The market capitalization of Regeneron Pharmaceuticals is US$32.05 billion. Regeneron Pharmaceuticals has a price to earnings ratio (PE ratio) of 17.11.

Ask ADVFN Intelligence (AI)

0R2M Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
100296.6296.6296.6177296.6DE
400296.6296.6296.61550296.6DE
1200296.6296.6296.61261296.6DE
2600296.6296.6296.61058296.6DE
5200296.6296.6296.61044296.6DE
15600296.6296.6296.61730296.6DE
26000296.6296.6296.61504296.6DE

0R2M - Frequently Asked Questions (FAQ)

What is the current Regeneron Pharmaceuticals share price?
The current share price of Regeneron Pharmaceuticals is US$ 296.60
How many Regeneron Pharmaceuticals shares are in issue?
Regeneron Pharmaceuticals has 108,072,000 shares in issue
What is the market cap of Regeneron Pharmaceuticals?
The market capitalisation of Regeneron Pharmaceuticals is USD 32.05B
What is the 1 year trading range for Regeneron Pharmaceuticals share price?
Regeneron Pharmaceuticals has traded in the range of US$ 296.60 to US$ 296.60 during the past year
What is the PE ratio of Regeneron Pharmaceuticals?
The price to earnings ratio of Regeneron Pharmaceuticals is 17.11
What is the cash to sales ratio of Regeneron Pharmaceuticals?
The cash to sales ratio of Regeneron Pharmaceuticals is 5.32
What is the reporting currency for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Regeneron Pharmaceuticals?
The latest annual turnover of Regeneron Pharmaceuticals is USD 14.2B
What is the latest annual profit for Regeneron Pharmaceuticals?
The latest annual profit of Regeneron Pharmaceuticals is USD 4.41B
What is the registered address of Regeneron Pharmaceuticals?
The registered address for Regeneron Pharmaceuticals is 28 LIBERTY STREET, NEW YORK, NEW YORK, 10005
What is the Regeneron Pharmaceuticals website address?
The website address for Regeneron Pharmaceuticals is www.regeneron.com
Which industry sector does Regeneron Pharmaceuticals operate in?
Regeneron Pharmaceuticals operates in the HEALTH CARE DIVERSIFIED sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AMGOAmigo Holdings Plc
0.475p
(72.73%)
11.81M
BEMBeowulf Mining Plc
22.00p
(25.71%)
104.2k
WSGWestminster Group Plc
1.30p
(23.81%)
1.4M
BLOEBlock Energy Plc
1.00p
(21.21%)
11.06M
SMLStrategic Minerals Plc
0.30p
(20.00%)
11.23M
SSTScottish Oriental Smaller Companies Trust Plc
290.00p
(-95.96%)
76.08k
ONCOncimmune Holdings Plc
1.40p
(-43.78%)
1.57M
BMTOBraime Group Plc
1,350.00p
(-20.59%)
547
PYXPyx Resources Limited
1.97p
(-19.76%)
398.74k
MGAMMorgan Advanced Materials Plc
214.50p
(-16.21%)
8.59M
TRPTower Resources Plc
0.0245p
(6.52%)
775.51M
UKOGUk Oil & Gas Plc
0.01125p
(-4.26%)
434.61M
TW.Taylor Wimpey Plc
114.25p
(2.05%)
345.64M
LLOYLloyds Banking Group Plc
72.32p
(0.84%)
344.78M
PREMPremier African Minerals Limited
0.0205p
(-11.26%)
300.49M

Discussion

View Full Feed
biotech48 biotech48 5 minutes ago
Ranchhand, they have laser focused getting the FDA approval soon. After that I feel that they will shift to the HemoDefend products, I also think that is where the money is.
CTSO
arizona1 arizona1 7 minutes ago
Pete Buttigieg should become the democratic press secretary. AOC should have been placed in leadership, but 84 year old Nancy Pelosi shitcanned what we wanted and put 74 year old Gerry Connelly who has Esophageal Cancer in her place instead. And you wonder why the dems don't show up for elections.
Mrhumble59 Mrhumble59 7 minutes ago
What is Tencents handle on Stocktwits? Any guesses? Maybe Shypokeme! Lol! They all just jump from board to board to make their daily 50 cent pieces.
HMBL
janice shell janice shell 7 minutes ago
Yes. Religion. Palestine. A pointless but very destructive war.

Into the Valley of Death rode the 600!!
delerious1 delerious1 7 minutes ago
Just 12 hours 'til NBRI and the rest of the OTC resumes trading....I must say it is unusual to have 4 or 5 odd ones consistently and constantly trashing the stock and shareholders.... for no apparent reason, especially when we will all know, very soon that this is the real deal .

ti
NBRI
XMaster2023 XMaster2023 8 minutes ago
Approval on Monday? Gap up!
NWBO
SHEEPWOLF SHEEPWOLF 9 minutes ago
$ILLR: HOT OFF THE PRESS: Triller Group Inc. (NASDAQ: ILLR): A Hidden Gem in the Creator Economy with Explosive Upside Potential

https://www.insiderfinancial.com/post/triller-group-inc-nasdaq-illr-a-hidden-gem-in-the-creator-economy-with-explosive-upside-potential
ILLR
SHEEPWOLF SHEEPWOLF 9 minutes ago
$ILLR: HOT OFF THE PRESS: Triller Group Inc. (NASDAQ: ILLR): A Hidden Gem in the Creator Economy with Explosive Upside Potential

https://www.insiderfinancial.com/post/triller-group-inc-nasdaq-illr-a-hidden-gem-in-the-creator-economy-with-explosive-upside-potential
ILLR
OMOLIVES OMOLIVES 10 minutes ago
I disagree. That is a good thing. They are increasing defense spending. They are not in control though currently. UK and France are another story with regards to what is going on currently.

This is the very first exhale since 2022 regarding this hot death mess. Let's see what the
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 11 minutes ago
Remember that Anavex is going to also spend hundreds of millions or more trying to advance A371, Rett, PDD, and possibly a preventative trial, too.

Further investment in trials will not affect stock price. AMZN had market cap in the tens of billions before even turning a profit due t
AMZN PDD
ducci1 ducci1 12 minutes ago
SPX Retrace: 39% 5955----50% 5992----66% 6029 !!
SPY
dbergh dbergh 14 minutes ago
'you are in no position to... you don't have
the cards.' Z said out loud, 'We are not playing cards' .. can only imagine what he was thinking, and didn't say.

Apr 10, 2024 — As of January 1, 2024, 146.15 million people were estimated to be residing on the Russian

Express1 Express1 14 minutes ago
Neb, are you on x? 
RITE
BDEZ BDEZ 15 minutes ago
Congresscritter Michael McCaul Trading $576 million

Just for reference, this is the Texas Congressman calling Tucker Carlson a “Russian Agent”

Congressman Michael McCaul Insider Trading $576 million dollars, makes $20 million per month and owns a $20 Million Dollar Pri
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 15 minutes ago
The FDA was that corrupt agency controlled by big pharma, now attempts to clean the FDA out are the problem.
So bad then and bad now. Geez.
Look, they will still be at work approving drugs.
The whole conversation is borderline OT.
AVXL
7longyears 7longyears 17 minutes ago
Amen,skibigtoe is a blow hard.
NWBO
michael702/ michael702/ 18 minutes ago
I agree with ORCA this week the earlier the better!
BLLB
Preciouslife1 Preciouslife1 19 minutes ago
https://www.mlb.com/news/shohei-ohtani-2025-spring-training-debut
oldstocks oldstocks 19 minutes ago
MWC Barcelona
https://www.mwcbarcelona.com

Doors open @ 8:30am
We would think OneMind Technologies would be there with Orange Business and Dell Technologies beings OneMind Technologies is located in Barcelona.

Mobile World Congress 2025!
The future
AFFU
Manspider Manspider 19 minutes ago
Bring it!! :-D
ASII
BDEZ BDEZ 19 minutes ago
100s of Muslims take over Times Square for the holiday of Ramadan

https://x.com/ViralNewsNYC/status/1896345642035028270
zab zab 21 minutes ago
You are truly becoming desperate. 
Eli's Gone Eli's Gone 21 minutes ago
Field: MAR 6 - 9 Arnold Palmer Invitational presented by Mastercard Arnold Palmer's Bay Hill Club & Lodge Orlando, FL • USA Signature Event Purse $20,000,000 FEDEXCUP 700 pts

https://www.pgatour.com/tournaments/2025/arnold-palmer-invitational-presented-by-mastercard/R2025009

Your Recent History

LSE
0R2M
Regeneron Pharmaceuticals
TG
27N
CANNOVUM
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads